From September 11 to 14, 2024, Saigon Exhibition and Convention Center in District 7, Ho Chi Minh City, hosted the 19th Pharmedi exhibition. This annual event has become a cornerstone for healthcare professionals, featuring over 300 exhibitors from more than 16 countries, showcasing innovations across the medical field. For Inspiry, this marked an exhilarating debut visit to Vietnam as Inspiry expanded its presence in this dynamic market.

Pharmedi 2024 offered a diverse platform divided into four main categories: pharmaceuticals, medical devices, biotechnology and analytical equipment, and beauty care products. The exhibition served as a hub for professionals to network, share insights, and explore the latest advancements in healthcare. With more than 5,000 attendees, the event was bustling with energy and opportunities.

On the third day of the exhibition, Inspiry eagerly engaged with exhibitors, some of whom they had previously met at other events. This interaction was invaluable, reinforcing existing relationships and paving the way for future collaborations. Notable country pavilions from Germany, Taiwan, Iran, South Korea, and China showcased their innovations, indicating a strong international presence. Moreover, numerous Vietnamese distributor companies participated, providing medical devices, pharmaceuticals, and supplements sourced from various countries, highlighting Vietnam’s growing role in the global healthcare market.

The primary objective of Inspiry’s participation in Pharmedi 2024 was to explore collaboration opportunities with various global players to expand into Indonesia. With Inspiry’s expertise in regulatory and market consultancy services—including feasibility studies, product registration, license holding, and business setup accompaniment—there is a robust foundation for foreign companies looking to navigate the Indonesian healthcare landscape.

Indonesia presents an enticing proposition for global investors, particularly in its rapidly growing healthcare sector, which is projected to expand at a remarkable 12% per year. The total health expenditure is expected to reach USD 70 billion in 2024, creating a fertile ground for investment. Inspiry is committed to assisting international enthusiasts through this dynamic market, particularly in the rapidly growing public and private sectors. Current government projects, such as SOPHI, SIHREN, and InPULS supported by the World Bank, offer partnership opportunities for the global players. At the same time, the private sector, which controls around 65% of Indonesia's total number of hospitals, is also a promising option.

Pharmedi 2024 proved to be more than just an exhibition for Inspiry; it was an opportunity to solidify its role as a trusted partner for businesses looking to enter the Indonesian market. Inspiry is excited about the potential collaborations initiated during the event and believes that now is the perfect time for foreign players to explore opportunities in Indonesia’s healthcare sector.

As Inspiry continues to expand its footprint internationally, the insights gained from Pharmedi 2024 will play a crucial role in shaping strategies for the Indonesian market. Inspiry invites everyone to explore the vast opportunities in Indonesia, emphasizing that collaboration is key to success. 

With the right partner, the journey into Indonesia’s healthcare landscape can be as smooth as crossing a well-constructed bridge. Inspiry serves as that bridge, connecting foreign businesses to this promising market and ensuring they thrive while contributing to the region's health advancements.  

In conclusion, Pharmedi 2024 was a resounding success for Inspiry, reaffirming its commitment to facilitating growth and collaboration in the Indonesian healthcare sector. With an eye toward the future, Inspiry is poised to lead the way in connecting global innovations with local opportunities.